Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 4

New England Journal of Medicine (NEJM)

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure | NEJM -

Interesting agent with both SGLT2 and SGLT1 inhibition. too bad it was stopped early, but a stunning result none the

  • Profile photo of Madelyn
    David Lanfear, MD

    Interesting agent with both SGLT2 and SGLT1 inhibition. too bad it was stopped early, but a stunning result none the less.

Read the full article here
See more from David Lanfear